Progress in advancing neurotechnologies is occurring at a time of change in health and social landscapes. As novel brain technologies traverse the realm of preclinical experimentation to real world treatments, questions of readiness, equitable patient access, legal, and intellectual rights surface.
On Monday, April 19, leaders of the Pan-Canadian Neurotechnology Ethics Collaboration; Plenary Speaker, Helen Mayberg, MD; and representatives from the Foundation engaged in an insightful discussion.
Read a White Paper from the Webinar >